This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.

5nmv

From Proteopedia

(Difference between revisions)

Jump to: navigation, search

Current revision

Crystal structure of 2F22 Fab fragment against TFPI1

Structural highlights

5nmv is a 3 chain structure with sequence from Homo sapiens and Mus. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:	X-ray diffraction, Resolution 1.65Å
Ligands:
Resources:	FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

TFPI1_HUMAN Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.

Publication Abstract from PubMed

BACKGROUND: Initiation of coagulation is induced by binding of activated factor VII (FVIIa) to tissue factor (TF) and activation of factor X (FX) in a process regulated by tissue factor pathway inhibitor (TFPI). TFPI contains three Kunitz-type protease inhibitor domains (K1-K3) of which K1 and K2 block the active sites of FVIIa and FXa respectively. OBJECTIVE: To produce a monoclonal antibody (mAb) directed towards K1, to characterize the binding epitope, and to study its effect on TFPI inhibition. METHODS: A monoclonal antibody, mAb2F22, was raised against the N-terminal TFPI(1-79) fragment. Binding data were obtained by surface plasmon resonance analysis. The Fab-fragment of mAb2F22, Fab2F22, was expressed and the structure of its complex with TFPI(1-79) determined by X-ray crystallography. Effects of mAb2F22 on TFPI inhibition were measured in buffer- and plasma- based systems. RESULTS: mAb2F22 bound exclusively to K1 of TFPI (KD ~1 nM) and not to K2. The crystal structure of Fab2F22/TFPI (1-79) mapped an epitope on K1 including seven residues upstream of the domain. TFPI inhibition of TF/FVIIa amidolytic activity was neutralized by mAb2F22, although the binding epitope on K1 did not include the P1 residue. Binding of mAb2F22 to K1 blocked TFPI inhibition of the FXa amidolytic activity and normalised haemostasis in haemophilia human A-like plasma and whole blood. CONCLUSION: mAb2F22 blocked TFPI inhibition of both FVIIa and FXa activities and mapped a FXa exosite for binding to K1. It reversed TFPI feed-back inhibition of TF/FVIIa-induced coagulation and restored clot formation in FVIII-neutralized human plasma and blood. This article is protected by copyright. All rights reserved.

Factor Xa and VIIa inhibition by Tissue Factor Pathway Inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.,Augustsson C, Svensson A, Kjaer B, Chao TY, Wenjuan X, Krogh BO, Breinholt J, Clausen JT, Hilden I, Petersen HH, Petersen LC J Thromb Haemost. 2018 Mar 12. doi: 10.1111/jth.14000. PMID:29532595^[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

↑ Augustsson C, Svensson A, Kjaer B, Chao TY, Wenjuan X, Krogh BO, Breinholt J, Clausen JT, Hilden I, Petersen HH, Petersen LC. Factor Xa and VIIa inhibition by Tissue Factor Pathway Inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain. J Thromb Haemost. 2018 Mar 12. doi: 10.1111/jth.14000. PMID:29532595 doi:http://dx.doi.org/10.1111/jth.14000

1 Structural highlights
2 Function
3 Publication Abstract from PubMed
4 See Also
5 References

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/5nmv"

Categories: Homo sapiens | Large Structures | Mus | Petersen HH | Svensson LA

@@ Line 1: / Line 1: @@
 ==Crystal structure of 2F22 Fab fragment against TFPI1==
-<StructureSection load='5nmv' size='340' side='right' caption='[[5nmv]], [[Resolution|resolution]] 1.65&Aring;' scene=''>
+<StructureSection load='5nmv' size='340' side='right'caption='[[5nmv]], [[Resolution|resolution]] 1.65&Aring;' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[5nmv]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5NMV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5NMV FirstGlance]. <br>
+<table><tr><td colspan='2'>[[5nmv]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Mus Mus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5NMV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5NMV FirstGlance]. <br>
-</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr>
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.65&#8491;</td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5nmv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5nmv OCA], [http://pdbe.org/5nmv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5nmv RCSB], [http://www.ebi.ac.uk/pdbsum/5nmv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5nmv ProSAT]</span></td></tr>
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5nmv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5nmv OCA], [https://pdbe.org/5nmv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5nmv RCSB], [https://www.ebi.ac.uk/pdbsum/5nmv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5nmv ProSAT]</span></td></tr>
 </table>
 == Function ==
-[[http://www.uniprot.org/uniprot/TFPI1_HUMAN TFPI1_HUMAN]] Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.
+[https://www.uniprot.org/uniprot/TFPI1_HUMAN TFPI1_HUMAN] Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma.
 <div style="background-color:#fffaf0;">
 == Publication Abstract from PubMed ==
@@ Line 18: / Line 19: @@
 </div>
 <div class="pdbe-citations 5nmv" style="background-color:#fffaf0;"></div>
+==See Also==
+*[[Tissue factor pathway inhibitor|Tissue factor pathway inhibitor]]
 == References ==
 <references/>
 __TOC__
 </StructureSection>
-[[Category: Petersen, H H]]
+[[Category: Homo sapiens]]
-[[Category: Svensson, L A]]
+[[Category: Large Structures]]
-[[Category: Fab]]
+[[Category: Mus]]
-[[Category: Immune system]]
+[[Category: Petersen HH]]
+[[Category: Svensson LA]]

5nmv

From Proteopedia

Current revision

Crystal structure of 2F22 Fab fragment against TFPI1

Structural highlights

Function

Publication Abstract from PubMed

See Also

References

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox